Gestational trophoblastic neoplasia epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
(Mahshid) |
No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}}{{AE}}{{MD}} | {{CMG}}{{AE}}{{MD}} | ||
==Overveiw== | ==Overveiw== | ||
The | The reported incidence of choriocarcinoma in the United States is 2 to 7 per 100,000 pregnancies. The U.S. age-standardized (1960 World Population Standard) incidence rate of choriocarcinoma is approximately 0.18/100,000 women between the ages of 15 - 49 years. | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
===Incidence=== | ===Incidence=== | ||
* The reported | * The reported incidence of choriocarcinoma in the United States is 2 to 7 per 100,000 pregnancies.<ref name= abc> General Information About Gestational Trophoblastic Disease National Cancer Institute. http://www.cancer.gov/types/gestational-trophoblastic/hp/gtd-treatment-pdq/#section/_1. Accessed on October7, 2015</ref> | ||
National Cancer Institute. http://www.cancer.gov/types/gestational-trophoblastic/hp/gtd-treatment-pdq/#section/_1. Accessed on October7, 2015</ref> | * The U.S. age-standardized (1960 World Population Standard) incidence rate of choriocarcinoma is approximately 0.18/100,000 women between the ages of 15 - 49 years.<ref name="pmid14602247">{{cite journal |vauthors=Altieri A, Franceschi S, Ferlay J, Smith J, La Vecchia C |title=Epidemiology and aetiology of gestational trophoblastic diseases |journal=Lancet Oncol. |volume=4 |issue=11 |pages=670–8 |date=November 2003 |pmid=14602247 |doi= |url=}}</ref> | ||
*The incidence in Europe ranges from 2 - 3 per 100, 000.<ref name="OlsenMellemkjaer1999">{{cite journal|last1=Olsen|first1=Jørgen H.|last2=Mellemkjaer|first2=Lene|last3=Gridley|first3=Gloria|last4=Brinton|first4=Louise|last5=Johansen|first5=Christoffer|last6=Kjaer|first6=Susanne Krüger|title=Molar pregnancy and risk for cancer in women and their male partners|journal=American Journal of Obstetrics and Gynecology|volume=181|issue=3|year=1999|pages=630–634|issn=00029378|doi=10.1016/S0002-9378(99)70504-1}}</ref><ref name="pmid1322822">{{cite journal |vauthors=Flam F, Lundström-Lindstedt V, Rutqvist LE |title=Incidence of gestational trophoblastic disease in Stockholm County, 1975-1988 |journal=Eur. J. Epidemiol. |volume=8 |issue=2 |pages=173–7 |date=March 1992 |pmid=1322822 |doi= |url=}}</ref><ref name="pmid5519491">{{cite journal |vauthors=Ringertz N |title=Hydatidiform mole, invasive mole and choriocarcinoma in Sweden 1958-1965 |journal=Acta Obstet Gynecol Scand |volume=49 |issue=2 |pages=195–203 |date=1970 |pmid=5519491 |doi= |url=}}</ref> | |||
* The U.S. age-standardized (1960 World Population Standard) incidence rate of choriocarcinoma is | ===Prevalence=== | ||
*The prevalance of choriocarcinoma in the United States is 0.075 - 0.01 per 100, 000.<ref name="pmid6705308">{{cite journal |vauthors=Buckley JD |title=The epidemiology of molar pregnancy and choriocarcinoma |journal=Clin Obstet Gynecol |volume=27 |issue=1 |pages=153–9 |date=March 1984 |pmid=6705308 |doi= |url=}}</ref><ref name="pmid11422477">{{cite journal |vauthors=Burton JL, Lidbury EA, Gillespie AM, Tidy JA, Smith O, Lawry J, Hancock BW, Wells M |title=Over-diagnosis of hydatidiform mole in early tubal ectopic pregnancy |journal=Histopathology |volume=38 |issue=5 |pages=409–17 |date=May 2001 |pmid=11422477 |doi= |url=}}</ref> | |||
*The prevalence rates from Southeast Asia are 1.5 - 2.5 times higher.<ref>Cortes R. Enfenpraded trophoblastic gestational. In obstetrician Clinica. Second edition. Edited by IZigheelboim, D Guariglia. Caracas, Editorial Disinlimed. 2005:374–379.</ref><ref>Kite NH, Lipscomb GH, Merrill K. Molar corneal ectopic pregnancy. Obstet Gynecol. 2002;99:689–692.</ref> | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
| Line 19: | Line 20: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | [[Category:Oncology]] | ||
[[Category:Medicine]] | [[Category:Medicine]] | ||
[[Category:Gynecology]] | [[Category:Gynecology]] | ||
[[Category:Surgery]] | [[Category:Surgery]] | ||
Revision as of 22:02, 20 February 2019
|
Gestational trophoblastic neoplasia Microchapters |
|
Differentiating Gestational trophoblastic neoplasia from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Gestational trophoblastic neoplasia epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Gestational trophoblastic neoplasia epidemiology and demographics |
|
FDA on Gestational trophoblastic neoplasia epidemiology and demographics |
|
CDC on Gestational trophoblastic neoplasia epidemiology and demographics |
|
Gestational trophoblastic neoplasia epidemiology and demographics in the news |
|
Blogs on Gestational trophoblastic neoplasia epidemiology and demographics |
|
Directions to Hospitals Treating Gestational trophoblastic neoplasia |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Monalisa Dmello, M.B,B.S., M.D. [2]
Overveiw
The reported incidence of choriocarcinoma in the United States is 2 to 7 per 100,000 pregnancies. The U.S. age-standardized (1960 World Population Standard) incidence rate of choriocarcinoma is approximately 0.18/100,000 women between the ages of 15 - 49 years.
Epidemiology and Demographics
Incidence
- The reported incidence of choriocarcinoma in the United States is 2 to 7 per 100,000 pregnancies.[1]
- The U.S. age-standardized (1960 World Population Standard) incidence rate of choriocarcinoma is approximately 0.18/100,000 women between the ages of 15 - 49 years.[2]
- The incidence in Europe ranges from 2 - 3 per 100, 000.[3][4][5]
Prevalence
- The prevalance of choriocarcinoma in the United States is 0.075 - 0.01 per 100, 000.[6][7]
- The prevalence rates from Southeast Asia are 1.5 - 2.5 times higher.[8][9]
References
- ↑ General Information About Gestational Trophoblastic Disease National Cancer Institute. http://www.cancer.gov/types/gestational-trophoblastic/hp/gtd-treatment-pdq/#section/_1. Accessed on October7, 2015
- ↑ Altieri A, Franceschi S, Ferlay J, Smith J, La Vecchia C (November 2003). "Epidemiology and aetiology of gestational trophoblastic diseases". Lancet Oncol. 4 (11): 670–8. PMID 14602247.
- ↑ Olsen, Jørgen H.; Mellemkjaer, Lene; Gridley, Gloria; Brinton, Louise; Johansen, Christoffer; Kjaer, Susanne Krüger (1999). "Molar pregnancy and risk for cancer in women and their male partners". American Journal of Obstetrics and Gynecology. 181 (3): 630–634. doi:10.1016/S0002-9378(99)70504-1. ISSN 0002-9378.
- ↑ Flam F, Lundström-Lindstedt V, Rutqvist LE (March 1992). "Incidence of gestational trophoblastic disease in Stockholm County, 1975-1988". Eur. J. Epidemiol. 8 (2): 173–7. PMID 1322822.
- ↑ Ringertz N (1970). "Hydatidiform mole, invasive mole and choriocarcinoma in Sweden 1958-1965". Acta Obstet Gynecol Scand. 49 (2): 195–203. PMID 5519491.
- ↑ Buckley JD (March 1984). "The epidemiology of molar pregnancy and choriocarcinoma". Clin Obstet Gynecol. 27 (1): 153–9. PMID 6705308.
- ↑ Burton JL, Lidbury EA, Gillespie AM, Tidy JA, Smith O, Lawry J, Hancock BW, Wells M (May 2001). "Over-diagnosis of hydatidiform mole in early tubal ectopic pregnancy". Histopathology. 38 (5): 409–17. PMID 11422477.
- ↑ Cortes R. Enfenpraded trophoblastic gestational. In obstetrician Clinica. Second edition. Edited by IZigheelboim, D Guariglia. Caracas, Editorial Disinlimed. 2005:374–379.
- ↑ Kite NH, Lipscomb GH, Merrill K. Molar corneal ectopic pregnancy. Obstet Gynecol. 2002;99:689–692.